A Trial to Investigate the Efficacy and Safety of Orally Administered Tolvaptan (OPC-41061) in Patients With Chronic Renal Failure Undergoing Hemodialysis or Hemodiafiltration
Clinical trial NCT02331680 · COMPLETED
Trial details
- NCT number
- NCT02331680
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2016-05-01
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.